NPPA notified regarding the computation of the retail price of Empagliflozin 12.5mg + Metformin Hydrochloride IP 1000mg (in extended-release form)

Feb 10, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 07, 2025, notified regarding the computation of the retail price of Empagliflozin 12.5mg + Metformin Hydrochloride IP 1000mg (in extended-release form).

It states that the price of each film-coated bilayered tablet containing: Empagliflozin 12.5mg + Metformin Hydrochloride IP 1000mg (in extended-release form) has been revised to Rs. 19.01/-.


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT